Naoero vs Oman: Death rate from Parkinson's disease
Naoero
1.44 deaths per 100,000 people
in 2021
Oman
1.5 deaths per 100,000 people
in 2021
Naoero rank
142nd
Oman rank
139th
Death rate from Parkinson's disease over time
- Naoero
- Oman
How they compare
Oman currently reports 1.5 deaths per 100,000 people against 1.44 deaths per 100,000 people in Naoero, a difference of 0.06 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Oman ahead.
Naoero ranks 142nd and Oman ranks 139th of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Naoero | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.35 deaths per 100,000 people | 1.38 deaths per 100,000 people | 0.034 deaths per 100,000 people | Oman |
| 2010s | 1.21 deaths per 100,000 people | 1.62 deaths per 100,000 people | 0.414 deaths per 100,000 people | Oman |
| 2020s | 1.37 deaths per 100,000 people | 1.73 deaths per 100,000 people | 0.36 deaths per 100,000 people | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Naoero or Oman?
- Oman, at 1.5 deaths per 100,000 people against 1.44 deaths per 100,000 people in Naoero as of 2021.
- What is the difference in death rate from parkinson's disease between Naoero and Oman?
- 0.06 deaths per 100,000 people, with Oman ahead.
- How many years of comparable data are there for Naoero and Oman?
- 22 years are reported by both, from 2000 to 2021.
- How do Naoero and Oman rank globally for death rate from parkinson's disease?
- Naoero ranks 142nd and Oman ranks 139th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.